ID PCD12_MOUSE Reviewed; 1180 AA. AC O55134; G5E847; DT 02-AUG-2002, integrated into UniProtKB/Swiss-Prot. DT 18-SEP-2013, sequence version 2. DT 24-JAN-2024, entry version 161. DE RecName: Full=Protocadherin-12 {ECO:0000305}; DE AltName: Full=Vascular cadherin-2 {ECO:0000303|PubMed:9651350}; DE AltName: Full=Vascular endothelial cadherin-2 {ECO:0000303|PubMed:9651350}; DE Short=VE-cad-2 {ECO:0000303|PubMed:9651350}; DE Short=VE-cadherin-2 {ECO:0000303|PubMed:9651350}; DE Contains: DE RecName: Full=Protocadherin-12, secreted form {ECO:0000250|UniProtKB:Q9NPG4}; DE Flags: Precursor; GN Name=Pcdh12 {ECO:0000312|MGI:MGI:1855700}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE RP SPECIFICITY. RC TISSUE=Brain capillary; RX PubMed=9651350; DOI=10.1074/jbc.273.28.17565; RA Telo P., Breviario F., Huber P., Panzeri C., Dejana E.; RT "Identification of a novel cadherin (vascular endothelial cadherin-2) RT located at intercellular junctions in endothelial cells."; RL J. Biol. Chem. 273:17565-17572(1998). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND GLYCOSYLATION. RX PubMed=15541725; DOI=10.1016/j.yexcr.2004.08.024; RA Rampon C., Prandini M.H., Bouillot S., Pointu H., Tillet E., Frank R., RA Vernet M., Huber P.; RT "Protocadherin 12 (VE-cadherin 2) is expressed in endothelial, trophoblast, RT and mesangial cells."; RL Exp. Cell Res. 302:48-60(2005). RN [5] RP TISSUE SPECIFICITY. RX PubMed=16269175; DOI=10.1016/j.placenta.2005.09.009; RA Bouillot S., Rampon C., Tillet E., Huber P.; RT "Tracing the glycogen cells with protocadherin 12 during mouse placenta RT development."; RL Placenta 27:882-888(2006). RN [6] RP DISRUPTION PHENOTYPE. RX PubMed=18477666; DOI=10.1152/physiolgenomics.00220.2007; RA Rampon C., Bouillot S., Climescu-Haulica A., Prandini M.H., Cand F., RA Vandenbrouck Y., Huber P.; RT "Protocadherin 12 deficiency alters morphogenesis and transcriptional RT profile of the placenta."; RL Physiol. Genomics 34:193-204(2008). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-859, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brown adipose tissue, Heart, Kidney, Lung, and Spleen; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [8] RP DISRUPTION PHENOTYPE. RX PubMed=22205043; DOI=10.1016/j.patbio.2011.11.005; RA Philibert C., Bouillot S., Huber P., Faury G.; RT "Protocadherin-12 deficiency leads to modifications in the structure and RT function of arteries in mice."; RL Pathol. Biol. 60:34-40(2012). CC -!- FUNCTION: Cellular adhesion molecule that may play an important role in CC cell-cell interactions at interendothelial junctions (PubMed:9651350). CC Acts as a regulator of cell migration, probably via increasing cell- CC cell adhesion (By similarity). Promotes homotypic calcium-dependent CC aggregation and adhesion and clusters at intercellular junctions CC (PubMed:9651350). Unable to bind to catenins, weakly associates with CC the cytoskeleton (PubMed:9651350). {ECO:0000250|UniProtKB:Q9NPG4, CC ECO:0000269|PubMed:9651350}. CC -!- SUBCELLULAR LOCATION: [Protocadherin-12]: Cell membrane CC {ECO:0000250|UniProtKB:Q9NPG4}; Single-pass type I membrane protein CC {ECO:0000255}. Cell junction {ECO:0000269|PubMed:9651350}. CC -!- SUBCELLULAR LOCATION: [Protocadherin-12, secreted form]: Secreted CC {ECO:0000250|UniProtKB:Q9NPG4}. Note=The secreted form is produced CC following cleavage by ADAM10. {ECO:0000250|UniProtKB:Q9NPG4}. CC -!- TISSUE SPECIFICITY: Expressed in endothelial cells: localizes in CC vasculogenic rather than angiogenic endothelium (PubMed:9651350, CC PubMed:15541725). Strongly expressed in a subset of invasive cells of CC the placenta, named glycogen-rich trophoblasts cells (at protein level) CC (PubMed:15541725). glycogen-rich trophoblasts cells originate from the CC from the ectoplacental cone where they rapidly form tight islets (at CC protein level) (PubMed:16269175). In adult mice, present at high level CC in mesangial cells of kidney glomeruli, while expression was not CC detected in other types of perivascular cells (PubMed:15541725). CC {ECO:0000269|PubMed:15541725, ECO:0000269|PubMed:16269175, CC ECO:0000269|PubMed:9651350}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:15541725}. CC -!- PTM: [Protocadherin-12]: Cleaved by ADAM10 close to the transmembrane CC domain to release the Protocadherin-12, secreted form in the serum. CC Cleavage results in reduced cellular adhesion in a cell migration CC assay. {ECO:0000250|UniProtKB:Q9NPG4}. CC -!- DISRUPTION PHENOTYPE: Mice are viable and fertile (PubMed:15541725, CC PubMed:18477666). Mice however show alterations in placental CC development that result in embryonic growth retardation: placentas are CC smaller and show limited angiogenesis and mis-segregation of the CC labyrinthine and intermediate layers (PubMed:18477666). Mice also CC display modifications in the structure and function of arteries, such CC as rearrangement of the arterial wall elastic fibers (PubMed:22205043). CC {ECO:0000269|PubMed:15541725, ECO:0000269|PubMed:18477666, CC ECO:0000269|PubMed:22205043}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Y08715; CAA69965.1; -; mRNA. DR EMBL; AC133646; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC152450; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH466528; EDL10091.1; -; Genomic_DNA. DR CCDS; CCDS29199.1; -. DR PIR; T31066; T31066. DR RefSeq; NP_059074.2; NM_017378.2. DR AlphaFoldDB; O55134; -. DR SMR; O55134; -. DR BioGRID; 207321; 1. DR IntAct; O55134; 1. DR STRING; 10090.ENSMUSP00000025311; -. DR GlyCosmos; O55134; 5 sites, No reported glycans. DR GlyGen; O55134; 5 sites. DR iPTMnet; O55134; -. DR PhosphoSitePlus; O55134; -. DR MaxQB; O55134; -. DR PaxDb; 10090-ENSMUSP00000025311; -. DR ProteomicsDB; 294340; -. DR Antibodypedia; 27396; 119 antibodies from 26 providers. DR DNASU; 53601; -. DR Ensembl; ENSMUST00000025311.8; ENSMUSP00000025311.6; ENSMUSG00000024440.14. DR GeneID; 53601; -. DR KEGG; mmu:53601; -. DR UCSC; uc008esb.1; mouse. DR AGR; MGI:1855700; -. DR CTD; 51294; -. DR MGI; MGI:1855700; Pcdh12. DR VEuPathDB; HostDB:ENSMUSG00000024440; -. DR eggNOG; KOG3594; Eukaryota. DR GeneTree; ENSGT00940000160403; -. DR HOGENOM; CLU_006480_1_2_1; -. DR InParanoid; O55134; -. DR OMA; ALFMSIC; -. DR OrthoDB; 4259465at2759; -. DR PhylomeDB; O55134; -. DR TreeFam; TF352008; -. DR BioGRID-ORCS; 53601; 0 hits in 77 CRISPR screens. DR ChiTaRS; Pcdh12; mouse. DR PRO; PR:O55134; -. DR Proteomes; UP000000589; Chromosome 18. DR RNAct; O55134; Protein. DR Bgee; ENSMUSG00000024440; Expressed in left lung lobe and 134 other cell types or tissues. DR ExpressionAtlas; O55134; baseline and differential. DR GO; GO:0005911; C:cell-cell junction; IDA:MGI. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0005886; C:plasma membrane; ISS:MGI. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; IDA:MGI. DR GO; GO:0007155; P:cell adhesion; IBA:GO_Central. DR GO; GO:0005977; P:glycogen metabolic process; IMP:MGI. DR GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:MGI. DR GO; GO:0060711; P:labyrinthine layer development; IMP:MGI. DR CDD; cd11304; Cadherin_repeat; 6. DR Gene3D; 2.60.40.60; Cadherins; 6. DR InterPro; IPR002126; Cadherin-like_dom. DR InterPro; IPR015919; Cadherin-like_sf. DR InterPro; IPR020894; Cadherin_CS. DR InterPro; IPR013164; Cadherin_N. DR PANTHER; PTHR24028; CADHERIN-87A; 1. DR PANTHER; PTHR24028:SF42; PROTOCADHERIN-12; 1. DR Pfam; PF00028; Cadherin; 4. DR Pfam; PF08266; Cadherin_2; 1. DR PRINTS; PR00205; CADHERIN. DR SMART; SM00112; CA; 6. DR SUPFAM; SSF49313; Cadherin-like; 5. DR PROSITE; PS00232; CADHERIN_1; 5. DR PROSITE; PS50268; CADHERIN_2; 6. DR Genevisible; O55134; MM. PE 1: Evidence at protein level; KW Calcium; Cell adhesion; Cell junction; Cell membrane; Glycoprotein; KW Membrane; Phosphoprotein; Reference proteome; Repeat; Secreted; Signal; KW Transmembrane; Transmembrane helix. FT SIGNAL 1..17 FT /evidence="ECO:0000255" FT CHAIN 18..1180 FT /note="Protocadherin-12" FT /id="PRO_0000003997" FT CHAIN 18..? FT /note="Protocadherin-12, secreted form" FT /evidence="ECO:0000250|UniProtKB:Q9NPG4" FT /id="PRO_0000444042" FT TOPO_DOM 18..716 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 717..737 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 738..1180 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 28..135 FT /note="Cadherin 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 136..244 FT /note="Cadherin 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 245..352 FT /note="Cadherin 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 355..460 FT /note="Cadherin 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 461..565 FT /note="Cadherin 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT DOMAIN 600..711 FT /note="Cadherin 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00043" FT REGION 857..930 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 973..1026 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1076..1104 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1156..1180 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 900..920 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1076..1090 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 859 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1064 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9NPG4" FT CARBOHYD 265 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 415 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 582 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 659 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 662 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CONFLICT 813 FT /note="Q -> E (in Ref. 1; CAA69965)" FT /evidence="ECO:0000305" SQ SEQUENCE 1180 AA; 128673 MW; 1E2BCC09DFCA4085 CRC64; MMLLLPFLLG LLGPGSYLFI SGDCQEVATV MVKFQVTEEV PSGTVIGKLS QELRVEERRG KAGDAFQILQ LPQALPVQMN SEDGLLSTSS RLDREKLCRQ EDPCLVSFDV LATGASALIH VEIQVLDIND HQPQFPKDEQ ELEISESASL HTRIPLDRAL DQDTGPNSLY SYSLSPSEHF ALDVIVGPDE TKHAELVVVK ELDRELHSYF DLVLTAYDNG NPPKSGISVV KVNVLDSNDN SPVFAESSLA LEIPEDTVPG TLLINLTATD PDQGPNGEVE FFFGKHVSPE VMNTFGIDAK TGQIILRQAL DYEKNPAYEV DVQARDLGPN SIPGHCKVLI KVLDVNDNAP SILITWASQT SLVSEDLPRD SFIALVSAND LDSGNNGLVH CWLNQELGHF RLKRTNGNTY MLLTNATLDR EQWPIYTLTV FAQDQGPQPL SAEKELQIQV SDVNDNAPVF EKSRYEVSTW ENNPPSLHLI TLKAHDADLG SNGKVSYRIK DSPVSHLVII DFETGEVTAQ RSLDYEQMAG FEFQVIAEDR GQPQLASSIS VWVSLLDAND NAPEVIQPVL SEGKATLSVL VNASTGHLLL PIENPSGMDP AGTGIPPKAT HSPWSFLLLT IVARDADSGA NGELFYSIQS GNDAHLFFLS PSLGQLFINV TNASSLIGSQ WDLGIVVEDQ GSPSLQTQVS LKVVFVTSVD HLRDSAHEPG VLSTPALALI CLAVLLAIFG LLLALFVSIC RTERKDNRAY NCREAESSYR HQPKRPQKHI QKADIHLVPV LRAHENETDE VRPSHKDTSK ETLMEAGWDS CLQAPFHLTP TLYRTLRNQG NQGELAESQE VLQDTFNFLF NHPRQRNASR ENLNLPESPP AVRQPLLRPL KVPGSPIARA TGDQDKEEAP QSPPASSATL RRQRNFNGKV SPRGESGPHQ ILRSLVRLSV AAFAERNPVE EPAGDSPPVQ QISQLLSLLH QGQFQPKPNH RGNKYLAKPG GSSRGTIPDT EGLVGLKPSG QAEPDLEEGP PSPEEDLSVK RLLEEELSSL LDPNTGLALD KLSPPDPAWM ARLSLPLTTN YRDNLSSPDA TTSEEPRTFQ TFGKTVGPGP ELSPTGTRLA STFVSEMSSL LEMLLGQHTV PVEAASAALR RLSVCGRTLS LDLATSGASA SEAQGRKKAA ESRLGCGRNL //